↓ Skip to main content

The convergence of radiation and immunogenic cell death signaling pathways

Overview of attention for article published in Frontiers in oncology, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
231 Dimensions

Readers on

mendeley
211 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The convergence of radiation and immunogenic cell death signaling pathways
Published in
Frontiers in oncology, January 2012
DOI 10.3389/fonc.2012.00088
Pubmed ID
Authors

Encouse B. Golden, Ilenia Pellicciotta, Sandra Demaria, Mary H. Barcellos-Hoff, Silvia C. Formenti

Abstract

Ionizing radiation (IR) triggers programmed cell death in tumor cells through a variety of highly regulated processes. Radiation-induced tumor cell death has been studied extensively in vitro and is widely attributed to multiple distinct mechanisms, including apoptosis, necrosis, mitotic catastrophe (MC), autophagy, and senescence, which may occur concurrently. When considering tumor cell death in the context of an organism, an emerging body of evidence suggests there is a reciprocal relationship in which radiation stimulates the immune system, which in turn contributes to tumor cell kill. As a result, traditional measurements of radiation-induced tumor cell death, in vitro, fail to represent the extent of clinically observed responses, including reductions in loco-regional failure rates and improvements in metastases free and overall survival. Hence, understanding the immunological responses to the type of radiation-induced cell death is critical. In this review, the mechanisms of radiation-induced tumor cell death are described, with particular focus on immunogenic cell death (ICD). Strategies combining radiotherapy with specific chemotherapies or immunotherapies capable of inducing a repertoire of cancer specific immunogens might potentiate tumor control not only by enhancing cell kill but also through the induction of a successful anti-tumor vaccination that improves patient survival.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Russia 1 <1%
Unknown 209 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 41 19%
Student > Master 30 14%
Researcher 29 14%
Student > Bachelor 19 9%
Student > Doctoral Student 15 7%
Other 34 16%
Unknown 43 20%
Readers by discipline Count As %
Medicine and Dentistry 57 27%
Biochemistry, Genetics and Molecular Biology 29 14%
Agricultural and Biological Sciences 29 14%
Immunology and Microbiology 18 9%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 21 10%
Unknown 50 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2012.
All research outputs
#22,778,604
of 25,394,764 outputs
Outputs from Frontiers in oncology
#15,927
of 22,440 outputs
Outputs of similar age
#228,625
of 250,240 outputs
Outputs of similar age from Frontiers in oncology
#100
of 161 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,440 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,240 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 161 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.